This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Bill Ackman's Herbalife Tumble Continues

Stocks in this article: JCP HLF AAPL CP APD

Least Favored in 2013: Featuring the year's shockers from Wall Street to Washington. Read Fed Policy shenanigans; Tech spies; SeaWorld tragedy; Caterpillar-China scandal; Bud Beer scandal; Bill Ackman's Herbalife; LIBOR rigging; Forex Scandal; and check out this video CEO Walk of Shame.

NEW YORK (TheStreet) -- There is nothing a little guy likes quite so much as watching a big, arrogant guy take a tumble.

We learned in 2013 that some big arrogant guys feel the same way. When Bill Ackman of Pershing Square fell hard on J.C. Penney (JCP), there were several who figured he should fall harder on Herbalife (HLF).

For those who don't remember,  Ackman once thought he could save J.C. Penney from a slow death and wound up nearly giving it a quick one. After taking a big position in the stock, he brought in Ron Johnson from Apple (AAPL), whose cure was so radical the customers fled in droves.

At this writing, the company's fate remains up in the air. But the fate of Ackman's investment in the stock is clear. He was a loser. So are many J.C. Penney employees and former employees. Investment bankers often forget they're playing with peoples' real lives when they hatch their schemes.

While Penney's was still crashing to Earth, Ackman became convinced Herbalife, a multi-level seller of health products, was really just a pyramid scheme. Late last year he posted his findings online and began selling the stock short.

[Read: I Always Double Down on 11]

This is where the fun starts for the little guys who resented Ackman's behavior toward Penney's.

Rather than join him in pounding Herbalife stock or just ignoring him and letting the short play out, rivals -- including Dan Loeb of Third Point, Georges Soros and Carl Icahn -- bought with both hands to support the stock, causing it to rise.

At this point the merits of Ackman's argument went out the window. What mattered was whether he won or lost, and the other titans were determined that he'd lose. We little guys knew that no matter what happened, some big guy was going to fall -- so we ran for the popcorn.

What is most curious about this story, scandalous or not, is that as Christmas comes around again this is a present that remains unopened, a story that has yet to end.

Ackman has cut back his bet, estimated to be worth $1 billion, and Herbalife stock has kept rising. Ackman admitted in November he'd lost $400 million to $500 million on Herbalife, but big wins on Canadian Pacific  (CP) and Air Products  (APD) meant he could hang on.

[Read: Herbalife Investors Win Battle]

Herbalife, meanwhile, has gone from strength to strength. As of this writing the stock was trading at over $75/share -- Ackman put his short on at around $40. After a KPMG auditor leaked data on the company, Herbalife fired the company, got a new audit from PriceWaterhouseCoopers and said that audit found nothing wrong.

Icahn, who has emerged as a sort of spokesman for the longs, and a hero to the little guys, got on TV to crow after the re-audit and said the stock was still undervalued.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs